Extant research indicates that youth with Inflammatory Bowel Disease (IBD) experience significantly higher rates of both depression and anxiety compared to their otherwise healthy peers. However, those data are based on general measures of depression and anxiety that don’t account for disease burden, IBD symptoms, or medication side effects. Diagnosing depression and anxiety in clinical care is based on the presence of symptoms and has evolved from the tradition of identification of psychopathology.